Melanie M. Frigault: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Gab2 requires membrane targeting and the met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the met receptor

Melanie M. Frigault, Monica A. Naujokas, Morag Park

Journal:

Journal of Cellular Physiology

Year:

2008

Language:

english

File:

PDF, 604 KB

english, 2008

2

Live Cell Imaging: Tips and Tools

Frigault, Melanie M., Lacoste, Judith, Swift, Jody L., Brown, Claire M.

Journal:

Biophysical Journal

Year:

2009

Language:

english

File:

PDF, 38 KB

english, 2009

3

Is target validation all we need?

Frigault, Melanie M, Barrett, J Carl

Journal:

Current Opinion in Pharmacology

Year:

2014

Language:

english

File:

PDF, 264 KB

english, 2014

4

Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer

Choueiri, Toni K., Plimack, Elizabeth, Arkenau, Hendrik-Tobias, Jonasch, Eric, Heng, Daniel Y.C., Powles, Thomas, Frigault, Melanie M., Clark, Edwin A., Handzel, Amir A., Gardner, Humphrey, Morgan, Sh

Journal:

Journal of Clinical Oncology

Year:

2017

Language:

english

File:

PDF, 927 KB

english, 2017

5

First-in-Human Phase I Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics and Anti-Tumor Activity

Gan, Hui K, Millward, Michael J., Hua, Ye, Qi, Chuan, Sai, Yang, Su, Weiguo, Wang, Jian, Zhang, Lilin, Frigault, Melanie M., Morgan, Shethah, Yang, Liu, Lickliter, Jason D

Journal:

Clinical Cancer Research

Year:

2019

Language:

english

File:

PDF, 4.43 MB

english, 2019

6

Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)

Rogers, Kerry A., Thompson, Philip A., Allan, John N., Coleman, Morton, Sharman, Jeff P., Cheson, Bruce D., Izumi, Raquel, Frigault, Melanie M., Quah, Cheng, Raman, Rakesh K., Wang, Min Hui, Kipps, Th

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 102 KB

english, 2019

7

Acalabrutinib with Obinutuzumab in Treatment-Naive (TN) and Relapsed/Refractory (R/R) Patients with Chronic Lymphocytic Leukemia (CLL): 3-Year Follow-Up

Woyach, Jennifer A., Rogers, Kerry A., Bhat, Seema, Blachly, James, Jianfar, Mojgan, Frigault, Melanie M., Hamdy, Ahmed, Izumi, Raquel, Munugalavadla, Veerendra, Quah, Cheng, Wang, Min Hui, Byrd, John

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 68 KB

english, 2019

8

Acalabrutinib plus Obinutuzumab in Treatment-NaÃ¯ve and Relapsed/Refractory Chronic Lymphocytic Leukemia

Woyach, Jennifer A., Blachly, James S., Rogers, Kerry A., Bhat, Seema A., Jianfar, Mojgan, Lozanski, Gerard, Weiss, David M., Andersen, Barbara L., Gulrajani, Michael, Frigault, Melanie M., Hamdy, Ahm

Journal:

Cancer Discovery

Year:

2020

File:

PDF, 3.51 MB

2020

9

Mechanisms of Acquired Resistance to Savolitinib, a Selective MET Inhibitor in MET -Amplified Gastric Cancer

Frigault, Melanie M., Markovets, Aleksandra, Nuttall, Barrett, Kim, Kyoung-Mee, Park, Se Hoon, Gangolli, Esha A., Mortimer, Peter G.S., Hollingsworth, Simon J., Hong, Jung Yong, Kim, Kyung, Kim, Seung

Journal:

JCO Precision Oncology

Year:

2020

File:

PDF, 1.83 MB

2020

10

Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib

Awan, Farrukh T., Schuh, Anna, Brown, Jennifer R., Furman, Richard R., Pagel, John M., Hillmen, Peter, Stephens, Deborah M., Woyach, Jennifer, Bibikova, Elena, Charuworn, Prista, Frigault, Melanie M.,

Journal:

Year:

2019

File:

PDF, 1.02 MB

2019

11

Efficacy of Savolitinib vs Sunitinib in Patients With MET -Driven Papillary Renal Cell Carcinoma

Choueiri, Toni K., Heng, Daniel Y. C., Lee, Jae Lyun, Cancel, Mathilde, Verheijen, Remy B., Mellemgaard, Anders, Ottesen, Lone H., Frigault, Melanie M., LâHernault, Anne, Szijgyarto, Zsolt, Signoret

Journal:

Year:

2020

File:

PDF, 420 KB

2020

12

A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer

Yang, Jin-Ji, Fang, Jian, Shu, Yong-Qian, Chang, Jian-Hua, Chen, Gong-Yan, He, Jian Xing, Li, Wei, Liu, Xiao-Qing, Yang, Nong, Zhou, Caicun, Huang, Jian An, Frigault, Melanie M., Hartmaier, Ryan, Ahme

Journal:

Investigational New Drugs

Year:

2020

File:

PDF, 753 KB

2020